UAI (UnifAINetwork) 24-hour amplitude 49.3%: Futures short pressure leads correction
Bitget Pulse2026/03/23 10:03Volatility Summary
In the past 24 hours, UAI price rebounded from a low of $0.22202 to a high of $0.33144 before sharply pulling back, currently quoted at $0.22802, with an overall amplitude of 49.3%. The 24-hour trading volume is approximately $14.43 million, down about 38.5%-59.8% from the previous day, indicating weaker market activity.
Brief Analysis of Abnormal Fluctuations
- Futures Market Led by Bears: Binance funding rate turned negative, triggering aggressive short positioning, resulting in the price dropping more than 20% from the peak and falling another 18% within one hour.
- Collective Correction in AI Sector: As an AI token, UAI was listed as the largest 24-hour loser in the AI coin sector (-17%), accompanied by simultaneous declines in DRV, FAI, etc., affected by the overall market correction.
No official announcements, large on-chain transfers, or whale movement records within 24 hours.
Market View and Outlook
Community sentiment is bearish: Most trading signals on X platform are short positions (such as 25x-75x leveraged shorts, targeting $0.30-$0.40 range), Instagram flagged UAI as the biggest decliner of the day (-27.46%). CoinGecko shows 75% bullish, but recent posts focus on the demand zone at $0.22-$0.25 support, and there is caution about further testing the $0.40 resistance level.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
